Molecular Partners Ag (MOLN) Receivables (2020 - 2026)
Molecular Partners Ag (MOLN) recorded Receivables of $1.88 million in Q3 2026, down 28.7% from $2.64 million a year earlier but up 13.3% from the prior quarter.
Molecular Partners Ag (MOLN) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, Molecular Partners Ag reported Receivables of $2.32 million, down 9.7% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of -6.4% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $2.57 million in FY2024 (+10.8%), $2.32 million in FY2023 (+109.7%), $1.1 million in FY2022 (-96.1%) and $28.07 million in FY2021 (+772.3%).
- Quarterly Receivables has ranged from $1.1 million in Q4 2022 to $28.07 million in Q4 2021 over the past five years.
- On a year-over-year basis, Receivables has declined for six consecutive quarters, with an average decline of 26.3% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 772.3% in Q4 2021, against a decline of 96.1% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.66 million (Q2 2026), $2.89 million (Q1 2026) and $2.32 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Molecular Partners Ag | 125.16 Mn | -243.89 Mn | - | 1.88 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.88 Mn |
| Jun 30, 2026 | 1.66 Mn |
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 4.52 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 3.95 Mn |
| Jun 30, 2024 | 20.70 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 20.69 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 19.49 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 28.07 Mn |
Molecular Partners Ag Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=MOLN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();